Kyowa Kirin Co (STU:KY4) Total Liabilities: €1,175 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:KY4 Kyowa Kirin Co Ltd STU:KY4
84 GF Score
Price €14.10
GF Value €15.89
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Kyowa Kirin Co Total Liabilities?

Kyowa Kirin Co STU:KY4 -1.40% 84 Total Liabilities is €1,175 Mil as of Dec. 2025. GuruFocus rates STU:KY4 with a GF Score™ of 84/100 and a GF Value™ of €15.89 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Kyowa Kirin Co's Total Liabilities for the quarter that ended in Dec. 2025 was €1,175 Mil.

Kyowa Kirin Co's quarterly Total Liabilities declined from Jun. 2025 (€1,347.33 Mil) to Sep. 2025 (€1,332.91 Mil) and declined from Sep. 2025 (€1,332.91 Mil) to Dec. 2025 (€1,175.04 Mil).

Kyowa Kirin Co's annual Total Liabilities increased from Dec. 2023 (€1,207.05 Mil) to Dec. 2024 (€1,344.53 Mil) but then declined from Dec. 2024 (€1,344.53 Mil) to Dec. 2025 (€1,175.04 Mil).

Kyowa Kirin Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for Kyowa Kirin Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kyowa Kirin Co Total Liabilities Chart

Kyowa Kirin Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,436.04 1,238.86 1,207.05 1,344.53 1,175.04

Kyowa Kirin Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,165.78 1,347.33 1,332.91 1,175.04 950.79
STU:KY4
84GF Score
Kyowa Kirin Co Ltd STU:KY4
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kyowa Kirin Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Kyowa Kirin Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=991.826+(0+181.684
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+1.534+0)
=1,175

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=6068.13-4893.086
=1,175

Kyowa Kirin Co's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=991.826+(0+181.684
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+1.534+0)
=1,175

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=6068.13-4893.086
=1,175

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €1,175 Mil mean?
Kyowa Kirin Co (STU:KY4) has a Total Liabilities of €1,175 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Kyowa Kirin Co and its competitors.
Is Kyowa Kirin Co's Total Liabilities too high?
Kyowa Kirin Co's current Total Liabilities is €1,175 Mil. Overall, Kyowa Kirin Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kyowa Kirin Co's Total Liabilities compare to ZTS and UTHR?
Kyowa Kirin Co's Total Liabilities of €1,175 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Kyowa Kirin Co and its competitors. Kyowa Kirin Co's current Total Liabilities is €1,175 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kyowa Kirin Co stock overvalued right now?
Based on GuruFocus' analysis, Kyowa Kirin Co (STU:KY4) is currently considered Modestly Undervalued. The stock's GF Value™ is €15.89, compared to a current price of €14.10 — trading 11.3% below its estimated fair value. The current Total Liabilities is €1,175 Mil. Kyowa Kirin Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Kyowa Kirin Co (STU:KY4), the current Total Liabilities is €1,175 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kyowa Kirin Co (STU:KY4) Overvalued in 2026?

Based on GuruFocus' analysis, Kyowa Kirin Co stock appears to be undervalued. The current stock price of €14.10 is trading 11.3% below its estimated GF Value™ of €15.89. GuruFocus considers Kyowa Kirin Co to be Modestly Undervalued.

Key valuation signals for STU:KY4:

  • Total Liabilities: €1,175 Mil
  • GF Value™: €15.89 vs. price of €14.10 (11.3% below fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the STU:KY4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kyowa Kirin Co Business Description

Address 1-9-2 Otemachi, Chiyoda-ku, Chiyoda-ku, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is engaged in research, development, manufacturing, sales, import and export of prescription pharmaceuticals. Its products include KHK4083/AMG 451, rocatinlimab; ziftomenib; OTL-203 KK8398, infigratinib; KHK4951, tivozanib; OTL-201; KK4277; KK2260; KK2269; KK2845; and KK8123.
84GF Score

Get the complete analysis for STU:KY4

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€14.10
Price
€15.89
GF Value